BCI
KNSA icon

Brinker Capital Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Brinker Capital Investments’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
17,775
-2,958
-14% -$153K 0.01% 1086
2026
Q1 		$998K Buy
20,733
+5,160
+33% +$229K 0.01% 1113
2025
Q4 		$642K Buy
15,573
+6,765
+77% +$271K ﹤0.01% 1481
2025
Q3 		$342K Buy
+8,808
New +$286K ﹤0.01% 1705

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Brinker Capital Investments's KNSA Position: Q2 2026 in Review

Brinker Capital Investments reduced its Kiniksa Pharmaceuticals (KNSA) stake by 14% in Q2 2026, selling an estimated $153K and leaving 17,775 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1086.

Brinker Capital Investments first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Brinker Capital Investments held 17,775 shares of Kiniksa Pharmaceuticals worth $1.14M as of Q2 2026.
  • Brinker Capital Investments sold 2,958 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $153K.
  • Kiniksa Pharmaceuticals made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1086 holding.
  • Brinker Capital Investments first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.